Science Explorer Interactive view Map

Coherus BioSciences (United States)

Research works
79
▲ 73% vs 2013–17
Citations
1.1k
13.4 per fractional work
Top-10% rate
9.2%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Coherus BioSciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.38× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 14.27× its world share, 6 worksImmunology and Micro…Neuroscience: 0.24× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.27× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.61× its world share, 0 worksChemical EngineeringChemistry: 0.55× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.31× its world share, 0 worksMaterials ScienceMathematics: 0.15× its world share, 0 worksMathematicsHealth Professions: 0.16× its world share, 0 worksHealth ProfessionsMedicine: 2.80× its world share, 21 worksMedicineNursing: 1.52× its world share, 0 worksNursingEconomics, Econometrics and Finance: 1.52× its world share, 1 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 14.3×. Every wedge is a field page.

Who are the top researchers at Coherus BioSciences (United States)?

Ranked on the composite score, Martin Oft lead among researchers whose main affiliation is Coherus BioSciences (United States).

  1. 1 Martin Oft United States · #92,518 worldwide 295 citations · 29 works
All ranked researchers at Coherus BioSciences (United States)

Which keywords describe research at Coherus BioSciences (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer, Chemotherapy, Monoclonal Antibodies, Immune Checkpoint Blockade, PD-1 and PD-L1, Cancer Therapy and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Tumor Microenvironment6▲ 33×7 topics
  2. Cancer5▲ 9.3×13 topics
  3. Chemotherapy5▲ 17×9 topics
  4. Monoclonal Antibodies4▲ 116×3 topics
  5. Immune Checkpoint Blockade3▲ 76×1 topic
  6. PD-1 and PD-L13▲ 76×1 topic
  7. Cancer Therapy3▲ 13×6 topics
  8. Inflammation3▲ 3.6×11 topics
  9. Immunotherapy3▲ 10×8 topics
  10. Cancer Immunotherapy3▲ 46×3 topics
  11. Biopharmaceuticals3▲ 132×3 topics
  12. Immunity3▲ 17×2 topics
  13. Immunogenicity2▲ 152×2 topics
  14. Clinical Trials2▲ 8.1×7 topics
  15. Therapeutic Antibodies2▲ 77×2 topics
  16. Bioanalytical Methods2▲ 253×1 topic
  17. Biosimilars2▲ 253×1 topic
  18. Hematological Malignancies2▲ 147×2 topics
  19. Antimicrobial Agents2▲ 276×1 topic
  20. Febrile Neutropenia2▲ 276×1 topic
  21. Targeted Therapy2▲ 19×5 topics
  22. Glycosylation2▲ 37×2 topics
  23. Angiogenesis2▲ 12×6 topics
  24. Antibody Engineering2▲ 70×1 topic
  25. Fc Receptors2▲ 70×1 topic
  26. Innate Immunity2▲ 12×2 topics
  27. Antigen Presentation1▲ 42×1 topic
  28. Dendritic Cells1▲ 41×1 topic
  29. Metabolism1▲ 7.2×4 topics
  30. Apoptosis1▲ 11×5 topics
  31. Activation1▲ 50×1 topic
  32. Cetuximab1▲ 36×2 topics
  33. Macrophage1▲ 42×1 topic
  34. Tumor Regression1▲ 27×2 topics
  35. CAR T Cells1▲ 39×1 topic
  36. Chimeric Antigen Receptor1▲ 39×1 topic
  37. Hematopoietic Stem Cells1▲ 33×2 topics
  38. Leukemia1▲ 35×2 topics
  39. Lymphoma1▲ 18×2 topics
  40. Molecular Subtypes1▲ 33×2 topics

Which research topics does Coherus BioSciences (United States) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Biosimilars and Bioanalytical Methods, Neutropenia and Cancer Infections and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 3 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 2 works
  3. 3 Neutropenia and Cancer Infections Oncology 2 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Immune cells in cancer Immunology 1 works
  7. 7 Colorectal Cancer Treatments and Studies Oncology 1 works
  8. 8 CAR-T cell therapy research Oncology 1 works
  9. 9 Cancer-related Molecular Pathways Oncology 1 works
  10. 10 Blood disorders and treatments Genetics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.5%not open48.5%

World: 28% of research is openly available.

with international co-authors18.0%domestic only82.0%

World: 19% is written across borders.

How has Coherus BioSciences (United States)'s research output changed?

Output in 2018–2022 was 73% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Redwood City

All research institutions in Redwood City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.